Colivelin

Catalog No.S9664 Batch:S966401

Technical Data

Formula

C₁₁₉H₂₀₆N₃₂O₃₅

Molecular Weight

2645.10

CAS No.

867021-83-8

Solubility (25°C)*

In vitro

Water

100 mg/mL (37.8 mM)

In vivo (Add solvents to the product individually and in order)

Clear solution

5% H2O 1 40% PEG 300 2 5% Tween 80 3 ddH2O

5.0mg/ml

Taking the 1 mL working solution as an example, add 50 μL of 100 mg/ml clarified H2O stock solution to 400 μL of PEG 300, mix evenly to clarify; add 50 μL of Tween 80 to the above system, mix evenly to clarify; Then continue to add 500 μL ddH2O to adjust the volume to 1 mL. The mixed solution should be used immediately for optimal results.

* <1 mg/ml means slightly soluble or insoluble.
* Please note that Selleck tests the solubility of all compounds in-house, and the actual solubility may differ slightly from published values. This is normal and is due to slight batch-to-batch variations.
* Room temperature shipping (Stability testing shows this product can be shipped without any cooling measures.)

Preparing Stock Solutions

Biological Activity

Description

Colivelin (CLN) is a brain-penetrant neuroprotective peptide with potent long-term capacity against Aβ deposition, neuronal apoptosis, and synaptic plasticity deficits in neurodegenerative disease. Colivelin is an activator of STAT3.

Targets

Aβ ^[1]

STAT3 ^[1]

In vitro

Colivelin, a brain penetrant neuroprotective peptide, significantly increases the p-STAT3 protein levels in BV-2 cells.^[2]

In vivo

Colivelin protects against ischemic brain injury and improves neurological outcomes, by elevating anti-apoptotic genes up-regulation and activates JAK/STAT3 signaling afetr ischemic stroke.^[1]

Protocol (from reference)

Cell Assay:^{^[2]}	Cell lines BV-2 cells Concentrations 50 µg/ml Incubation Time 4 h Method BV-2 cells are maintained at 37℃ with 5% CO₂. To build OGD models, BV-2 cells are washed with PBS for 3 times, and cultured in glucose-free DMEN and placed in a hypoxia incubation chamber filled with the gas mixture for 4 h at 37℃. The culture medium is then replaced by the normal medium containing 4.5 g/L glucose and cells are cultured under normoxic conditions for reoxygenation for 24 h. BV-2 cells are treated with 50 µg/ml rmMFG-E8 or/and Colivelin TFA, respectively. The expression changes of proteins (p-STAT3 and SOCS3) are analyzed by Western blot assay.
Animal Study:^{^[1]}	Animal Models Male C57BL/6 mice of middle cerebral artery occlusion (MCAO) models Dosages 1 mg/kg Administration i.p.

Cell Assay:^{^[2]}

Cell lines
BV-2 cells
Concentrations
50 µg/ml
Incubation Time
4 h
Method
BV-2 cells are maintained at 37℃ with 5% CO₂. To build OGD models, BV-2 cells are washed with PBS for 3 times, and cultured in glucose-free DMEN and placed in a hypoxia incubation chamber filled with the gas mixture for 4 h at 37℃. The culture medium is then replaced by the normal medium containing 4.5 g/L glucose and cells are cultured under normoxic conditions for reoxygenation for 24 h. BV-2 cells are treated with 50 µg/ml rmMFG-E8 or/and Colivelin TFA, respectively. The expression changes of proteins (p-STAT3 and SOCS3) are analyzed by Western blot assay.

Animal Study:^{^[1]}

Animal Models
Male C57BL/6 mice of middle cerebral artery occlusion (MCAO) models
Dosages
1 mg/kg
Administration
i.p.

References

Selleck's Colivelin has been cited by 6 publications

Intracellular CIRP promotes liver regeneration while extracellular CIRP induces ER stress after partial hepatectomy in mice [ Research Square, 2024, 10.21203/rs.3.rs-3840462/v1]	PubMed: none
TIPE1 inhibits osteosarcoma tumorigenesis and progression by regulating PRMT1 mediated STAT3 arginine methylation [ Cell Death Dis, 2022, 13-9:815]	PubMed: 36151091
IL-27 promotes decidualization via the STAT3-ESR/PGR regulatory axis [ J Reprod Immunol, 2022, 151:103623]	PubMed: 35430461
Complement C5a induces the generation of neutrophil extracellular traps by inhibiting mitochondrial STAT3 to promote the development of arterial thrombosis [ Thromb J, 2022, 20(1):24]	PubMed: 35488279
HCRP-1 alleviates the malignant phenotype and angiogenesis of oral squamous cell carcinoma cells via the downregulation of the EGFR/STAT3 signaling pathway [ Oncol Lett, 2022, 24(5):387]	PubMed: 36276496
Shikonin alleviates choroidal neovascularization by inhibiting proangiogenic factor production from infiltrating macrophages [ Exp Eye Res, 2021, 213:108823]	PubMed: 34752817

RETURN POLICY
Selleck Chemical’s Unconditional Return Policy ensures a smooth online shopping experience for our customers. If you are in any way unsatisfied with your purchase, you may return any item(s) within 7 days of receiving it. In the event of product quality issues, either protocol related or product related problems, you may return any item(s) within 365 days from the original purchase date. Please follow the instructions below when returning products.

SHIPPING AND STORAGE
Selleck products are transported at room temperature. If you receive the product at room temperature, please rest assured, the Selleck Quality Inspection Department has conducted experiments to verify that the normal temperature placement of one month will not affect the biological activity of powder products. After collecting, please store the product according to the requirements described in the datasheet. Most Selleck products are stable under the recommended conditions.

NOT FOR HUMAN, VETERINARY DIAGNOSTIC OR THERAPEUTIC USE.